Tuesday, 20 March 2018

Seattle Genetics' Hodgkin's lymphoma drug gets U.S. approval

U.S. regulators on Tuesday approved Seattle Genetics Inc's Adcetris as part of a chemotherapy cocktail to treat advanced Hodgkin's lymphoma in newly diagnosed patients.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)